These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28061040)

  • 61. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel application of discrete choice experiment methodology to understand how clinicians around the world triage palliative care needs: A research protocol.
    Russell B; Vogrin S; Philip J; Hennessy-Anderson N; Collins A; Burchell J; Le B; Brand C; Hudson P; Sundararajan V
    Palliat Support Care; 2019 Feb; 17(1):66-73. PubMed ID: 30602406
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Developing attributes for discrete choice experiments in health: a systematic literature review and case study of alcohol misuse interventions.
    Helter TM; Boehler CE
    J Subst Use; 2016 Nov; 21(6):662-668. PubMed ID: 27695386
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Attributes Development for Pharmaceutical Subsidization: A Qualitative Study.
    Afsharmanesh G; Mehralian G; Peiravian F
    Iran J Pharm Res; 2020; 19(1):203-217. PubMed ID: 32922481
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Taking the Shortcut: Simplifying Heuristics in Discrete Choice Experiments.
    Veldwijk J; Marceta SM; Swait JD; Lipman SA; de Bekker-Grob EW
    Patient; 2023 Jul; 16(4):301-315. PubMed ID: 37129803
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
    Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
    BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Systematic Review Comparing the Acceptability, Validity and Concordance of Discrete Choice Experiments and Best-Worst Scaling for Eliciting Preferences in Healthcare.
    Whitty JA; Oliveira Gonçalves AS
    Patient; 2018 Jun; 11(3):301-317. PubMed ID: 29177797
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.
    Reed Johnson F; Lancsar E; Marshall D; Kilambi V; Mühlbacher A; Regier DA; Bresnahan BW; Kanninen B; Bridges JF
    Value Health; 2013; 16(1):3-13. PubMed ID: 23337210
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening.
    de Bekker-Grob EW; Hol L; Donkers B; van Dam L; Habbema JD; van Leerdam ME; Kuipers EJ; Essink-Bot ML; Steyerberg EW
    Value Health; 2010; 13(2):315-23. PubMed ID: 19912597
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Physical Activity Preferences of People Living with Brain Injury: Formative Qualitative Research to Develop a Discrete Choice Experiment.
    Haynes A; Howard K; Johnson L; Williams G; Clanchy K; Tweedy S; Scheinberg A; Chagpar S; Wang B; Vassallo G; Ashpole R; Sherrington C; Hassett L
    Patient; 2023 Jul; 16(4):385-398. PubMed ID: 37204699
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Using discrete choice experiments to develop and deliver patient-centered psychological interventions: a systematic review.
    McGrady ME; Pai ALH; Prosser LA
    Health Psychol Rev; 2021 Jun; 15(2):314-332. PubMed ID: 31937184
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.
    Janssen EM; Hauber AB; Bridges JFP
    Value Health; 2018 Jan; 21(1):59-68. PubMed ID: 29304942
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force.
    Hauber AB; González JM; Groothuis-Oudshoorn CG; Prior T; Marshall DA; Cunningham C; IJzerman MJ; Bridges JF
    Value Health; 2016 Jun; 19(4):300-15. PubMed ID: 27325321
    [TBL] [Abstract][Full Text] [Related]  

  • 76. How to do (or not to do) ... Designing a discrete choice experiment for application in a low-income country.
    Mangham LJ; Hanson K; McPake B
    Health Policy Plan; 2009 Mar; 24(2):151-8. PubMed ID: 19112071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.
    Mühlbacher AC; Bridges JF; Bethge S; Dintsios CM; Schwalm A; Gerber-Grote A; Nübling M
    Eur J Health Econ; 2017 Mar; 18(2):155-165. PubMed ID: 26846922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Two discrete choice experiments on laboratory safety decisions and practices.
    Wirth O; Foreman AM; Friedel JE; Andrew ME
    J Safety Res; 2020 Dec; 75():99-110. PubMed ID: 33334498
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis.
    Hiligsmann M; van Durme C; Geusens P; Dellaert BG; Dirksen CD; van der Weijden T; Reginster JY; Boonen A
    Patient Prefer Adherence; 2013; 7():133-9. PubMed ID: 23412964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.